ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2024

Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data.

Astrid M Manuel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.